Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Identify the primary factors that influence the Dow Jones daily value, including price movements, dividends, and divisor adjustments that sway the index.
20,791 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Gen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
Oklo is combining AI with nuclear reactor design to shorten development timelines and improve safety. This article br...
The AI memory boom has traders watching the Roundhill Memory ETF. With a potential SK Hynix ADR list around July 10, ...
Is IonQ stock overvalued right? This in-depth guide breaks down the technology, market timing, and financials to help...
Pi2Day brings three new services to Pi Network, expanding into AI, identity, and third-party apps. Markets respond wi...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...
I’ve spent week world’s top AI talks and the takeaway is sharp: talent battles and new pricing models will ripple thr...
Memory names slide as risk appetite shifts toward cyclicals, but persistent supply constraints and improving contract...
The space economy is expanding, yet investing in it without a plan can blow up portfolios. This guide explains why wa...
NVIDIA commands the AI software and platform stack, while Micron powers the memory that feeds it. Investors bet on wh...
Investing in biotech can be bold. This piece lays out practical scenarios for what much could $1,000 invested in Viki...